Reviewed by Sarim Mir, MD — Board-Certified Neurologist, Mir Neurology (Hagerstown & Cumberland, MD)
Key takeaways
- The FDA approved tirzepatide (Zepbound) as the first-ever medication for moderate-to-severe obstructive sleep apnea (OSA) — but only in adults who also have obesity.
- It works by treating the underlying weight that drives airway collapse, not by holding the airway open like a CPAP does.
- 2026 research shows GLP-1–type drugs can meaningfully reduce apnea events and, for some patients, reduce reliance on CPAP — but it is not a guaranteed CPAP replacement for everyone.
- You still need a diagnosis and ongoing management by a sleep-trained physician. Don’t stop CPAP on your own.
What changed
For decades, obstructive sleep apnea had no approved drug — the standard was a CPAP machine, an oral appliance, or surgery. That changed when the FDA approved Zepbound (tirzepatide) as the first medication indicated for OSA in adults with obesity. Newer 2026 analyses go further, showing that GLP-1–based therapies can lower the apnea-hypopnea index (AHI) — the core measure of sleep apnea severity — and may reduce how much some patients depend on CPAP.

What is obstructive sleep apnea, in plain terms
During sleep, the muscles around your throat relax. In OSA, the airway collapses or narrows, briefly cutting off breathing — sometimes dozens of times an hour. Each episode jolts your brain awake just enough to restart breathing, which is why people with OSA feel exhausted despite “sleeping” all night. Untreated OSA raises the risk of high blood pressure, heart disease, stroke, and daytime accidents — which is why neurologists take it seriously.
How Zepbound is different from a CPAP
A CPAP mechanically splints the airway open with air pressure every night. Zepbound is a once-weekly injection that activates GLP-1 and GIP hormone receptors to reduce appetite and drive weight loss. Because excess weight around the neck and abdomen is a major cause of airway collapse, losing that weight can reduce the number and severity of apnea events at the source. In other words: CPAP treats the mechanics tonight; Zepbound treats one of the root causes over months.

So — can it replace CPAP?
For some patients with obesity-driven OSA, yes, it may reduce or eliminate the need for CPAP over time. For many others, it works best alongside CPAP, not instead of it. It is not approved or appropriate for people whose sleep apnea isn’t weight-related, and it carries its own considerations (nausea, cost/insurance, and the need for medical supervision).
The most important point: never stop CPAP on your own. Whether you can taper off should be decided with a physician, ideally confirmed by a repeat sleep study.
What this means for patients in Western Maryland
At Mir Neurology, we evaluate sleep apnea as part of comprehensive neurology and sleep care across Hagerstown and Cumberland, MD. If you’re wondering whether you’re a candidate for newer treatments like Zepbound — or whether your current CPAP is still the right call — the first step is a proper evaluation and, often, a sleep study. Explore the full range of conditions we treat.
Call (301) 797-7600 to request an appointment, or request one online.
Frequently asked questions
Is Zepbound a cure for sleep apnea? No. It treats an underlying driver (obesity) and can reduce apnea severity, but OSA still needs ongoing monitoring.
Will insurance cover it for sleep apnea? Coverage varies and often requires prior authorization. Bring this up at your evaluation so we can help document medical necessity.
Can I get it if I’m not overweight? The OSA approval is specifically for adults with obesity. If your apnea has other causes, other treatments are more appropriate.
—
Medical disclaimer: This article is for general education and is not medical advice. Talk to a qualified physician before starting or stopping any treatment.
Sources: FDA — First Medication for Obstructive Sleep Apnea; Komodo Health — FDA GLP-1 Approval May Reduce Reliance on CPAP.
Need to talk to a neurologist about this?
Mir Neurology offers same-week appointments in Hagerstown & Cumberland, MD. No referral needed for most plans.
